Neurogenic Detrusor Overactivity clinical trials

Explore recruiting neurogenic detrusor overactivity clinical trials.

Recruiting neurogenic detrusor overactivity studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neurogenic Detrusor Overactivity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age with Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)

Lithuania, Croatia, Latvia, Denmark, Romania, Belgium +3 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 3, Open Label, Multicenter, Baseline-controlled Sequential Dose Titration Study Followed by a Fixed Dose Observation Period to Evaluate Pharmacokinetics, Efficacy and Safety of Mirabegron Prolonged-release Microgranula-based Suspension in Children from 6 Months to Less Than 3 Years of Age with Neurogenic Detrusor Overactivity

Denmark, Belgium, Poland, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neurogenic Detrusor Overactivity trials by city

Neurogenic Detrusor Overactivity in Toronto Neurogenic Detrusor Overactivity in Vancouver Neurogenic Detrusor Overactivity in Montreal Neurogenic Detrusor Overactivity in Calgary Neurogenic Detrusor Overactivity in Edmonton Neurogenic Detrusor Overactivity in Ottawa Neurogenic Detrusor Overactivity in Winnipeg Neurogenic Detrusor Overactivity in Quebec City Neurogenic Detrusor Overactivity in Hamilton Neurogenic Detrusor Overactivity in Kitchener Neurogenic Detrusor Overactivity in London Neurogenic Detrusor Overactivity in Halifax Neurogenic Detrusor Overactivity in New York Neurogenic Detrusor Overactivity in Los Angeles Neurogenic Detrusor Overactivity in Chicago Neurogenic Detrusor Overactivity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease